📊 Evidence-Based Reference

Peripherally Inserted Central Venous Catheter

Catheter Technology

Compare similar devices

Summary: A peripherally inserted central venous catheter (PICC) is used for prolonged intravenous therapy. Key evidence highlights its efficacy in outpatient antibiotic treatment and its safety profile in various clinical settings.

FDA Clearance Information

Pathway ? 510(k)
Number ? K871080 ↗
Decision Date ? August 12, 1987
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The peripherally inserted central venous catheter by Catheter Technology was cleared by the FDA via the 510k pathway on August 12, 1987. It is classified as a Class 2 device.

What It Is

A peripherally inserted central venous catheter (PICC) is a long, thin tube inserted through a peripheral vein and advanced to a central vein. It is intended for prolonged intravenous therapy, including antibiotics, chemotherapy, and parenteral nutrition.

FDA-Cleared Indications

  • Prolonged intravenous administration of fluids, medications, or other therapeutic substances
  • Central venous access when peripheral access is inadequate or repeated venipuncture should be avoided

Clinical Applications

  • Long-term intravenous antibiotic therapy
  • Administration of chemotherapy and other cancer treatments
  • Delivery of parenteral nutrition
  • Repeated intravenous medications or fluids requiring reliable central venous access

Reported off-label uses

  • Administration of selected blood products or blood sampling when the catheter lumen and institutional protocols permit
  • Extended outpatient intravenous therapy for conditions not specifically described in the individual product labeling

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 14 studies, encompassing retrospective analyses and case series, published between 2023 and 2024. These studies evaluate the efficacy and safety of PICCs in various patient populations.

Reported Outcomes

Published studies report that PICCs are effective in outpatient intravenous antibiotic therapy for spinal infections, with a high absence of spondylodiscitis (99%) and no catheter-related complications. In pediatric acute leukemia, PICCs are increasingly used for long-term access, though data remain limited.

Safety Profile

Reported complications include infections, thrombosis, and mechanical issues, particularly in patients with hematological malignancies. However, one study noted no catheter-related complications in outpatient antibiotic therapy for spinal infections.

Evidence Limitations

Evidence gaps include limited data on long-term outcomes in pediatric populations and the need for more prospective studies to better understand complication rates. Further research is needed to optimize PICC use in diverse clinical settings.

Practical Considerations

  • Common insertion sites include the basilic, brachial, or cephalic veins of the upper arm; the catheter tip is advanced toward the lower superior vena cava or cavoatrial junction.
  • Catheter diameter, length, number of lumens, and maximum flow rate must match the prescribed therapy and the patient's venous anatomy.
  • Use only compatible medications and flushing solutions; follow the manufacturer's instructions for placement confirmation, dressing changes, flushing, and maintenance.
  • MRI safety depends on the specific catheter and any reinforcing components. Confirm the exact product's MR Safe, MR Conditional, or MR Unsafe labeling before scanning.
  • Potential complications include infection, thrombosis, catheter occlusion, malposition, bleeding, venous injury, and catheter breakage or embolization. Avoid or use caution with severe upper-extremity venous thrombosis, local infection, or anatomy that prevents safe placement.

Procedures that use this device

Frequently Asked Questions

What are the clinical indications for peripherally inserted central venous catheter?

Indications include prolonged intravenous therapy for infections, chemotherapy, and parenteral nutrition.

What outcomes have been reported in clinical studies?

Studies report high efficacy in outpatient antibiotic therapy for spinal infections and successful use in pediatric leukemia.

What complications have been reported?

Complications include infections, thrombosis, and mechanical issues, though some studies report no complications in specific settings.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you